Mitchell Shawnte
- SEC CIK
- 0001749432
In the past year, 1 open-market sale filing worth $951.5K and no purchases.
Current role at each company
- OLMA Olema Pharmaceuticals, Inc.CHIEF LEGAL OFFICERas of Mar 5, 2026
- CIK 0001375151EVP, GC & Secretaryas of Mar 9, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $951.5K
- 1 filing
- Net
- −$951.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Mitchell Shawnte as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OLMA Olema Pharmaceuticals, Inc.
CHIEF LEGAL OFFICER2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 (view filing) | Mar 3-4 | 2 days | Mitchell ShawnteCHIEF LEGAL OFFICER | SSale | −39.8K | $23.78 | −$945.7K | −99.4%233 after | 2 lots |
| Mar 5, 2026 (view filing) | Mar 4 | 1 day | Mitchell ShawnteCHIEF LEGAL OFFICER | SSaleComon Stock | −233 | $24.69 | −$5.75K | −100.0%0 after |